2.49

5.51% +0.13

Nautilus Biotechnology Inc (NAUT)

Overview News Price History Option Chain Discussions Forecast

Nautilus Biotechnology Inc stock is currently priced at $2.49, with a 24-hour trading volume of 28,706. It has seen a +5.51% increased in the last 24 hours and a -4.60% declined in the past month. The chart indicates a potential bullish trend, as the stock is above the $2.43 pivot point. If it approaches the $2.53 resistance level, significant changes may occur.

Previous Close:

$2.36

Open:

$2.42

24h Volume:

28,706

Market Cap:

$311.49M

Revenue:

Net Income/Loss:

$-63.68M

P/E Ratio:

-5.2979

EPS:

-0.47

Net Cash Flow:

$-54.15M

1W Performance:

+1.22%

1M Performance:

-4.60%

6M Performance:

-0.80%

1Y Performance:

+2.05%

1D Range:

$2.3508

$2.52

52W Range:

$2.16

$4.65

Nautilus Biotechnology Inc Stock (NAUT) Company Profile

Name

Nautilus Biotechnology Inc

Sector

Healthcare (1191)

Industry

Biotechnology (688)

Phone

206-333-2001

Address

425 Pontius Avenue North, Suite 202, Seattle

Employee

Twitter

Next Earnings Date

2024-04-30

Latest SEC Filings

NAUT's Discussions on Twitter

Nautilus Biotechnology Inc Stock (NAUT) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jan-06-22	Initiated	Morgan Stanley	Equal-Weight
Nov-02-21	Initiated	Cowen	Outperform
Aug-04-21	Initiated	Goldman	Neutral
Jul-13-21	Initiated	Jefferies	Buy

Nautilus Biotechnology Inc Stock (NAUT) Latest News

Nautilus Biotechnology to Participate in the TD Cowen 44ᵗʰ Annual Healthcare Conference

GlobeNewswire Inc.

Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development

GlobeNewswire Inc.

Nautilus Biotechnology Reports Third Quarter 2023 Financial Results

GlobeNewswire Inc.

Nautilus Biotechnology Inc Stock (NAUT) Financials Data

Nautilus Biotechnology Inc (NAUT) Net Income 2024

NAUT net income (TTM) was -$63.67 million for the quarter ending December 31, 2023, a -9.93% decrease year-over-year.

Nautilus Biotechnology Inc (NAUT) Cash Flow 2024

NAUT recorded a free cash flow (TTM) of -$54.15 million for the quarter ending December 31, 2023, a -12.51% decrease year-over-year.

Nautilus Biotechnology Inc (NAUT) Earnings per Share 2024

NAUT earnings per share (TTM) was -$0.52 for the quarter ending December 31, 2023, a -10.64% decline year-over-year.

Nautilus Biotechnology, Inc., a development stage life sciences company, engages in creating a platform technology for quantifying and unlocking the complexity of the human proteome. It develops Nautilus Platform, a proteomics platform that includes end-to-end solution comprised of instruments, consumables, and software analysis. The company is headquartered in Seattle, Washington.